Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ertugliflozin After Acute Myocardial Infarction in T2DM Patients
NCT07621380Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 4 trial of ertugliflozin in myocardial infarction (MI), type 2 diabetes mellitus (T2DM), sponsored by Zhongshan Hospital, Fudan University. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
ertugliflozin
03
Conditions
myocardial infarction (MI)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07621380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07621380.